AbstractThe serine/threonine checkpoint kinase 2 (Chk2) is an attractive molecular target for the development of small molecule inhibitors to treat cancer. Here, we report the rational design of Chk2 inhibitors that target the gatekeeper-dependent hydrophobic pocket located behind the adenine-binding region of the ATP-binding site. These compounds exhibit IC50 values in the low nanomolar range and are highly selective for Chk2 over Chk1. X-ray crystallography was used to determine the structures of the inhibitors in complex with the catalytic kinase domain of Chk2 to verify their modes of binding
Protein kinases represent an attractive target in oncology drug discovery. Most of kinase inhibitors...
Protein kinases represent an attractive target in oncology drug discovery. Most of kinase inhibitors...
CHK2 is a checkpoint kinase involved in the ATM-mediated response to double-strand DNA breaks. Its p...
Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response to DNA d...
<div><p>Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response ...
Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response to DNA d...
Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response to DNA d...
Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response to DNA d...
5-(Hetero)aryl-3-(4-carboxamidophenyl)-2-aminopyridine inhibitors of CHK2 were identified from high ...
5-(Hetero)aryl-3-(4-carboxamidophenyl)-2-aminopyridine inhibitors of CHK2 were identified from high ...
5-(3-Chlorophenylamino)benzo[c] [2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical s...
Inhibition of the cell cycle is widely considered as a new approach toward treatment for diseases ca...
Protein kinases are key components in cellular signalling pathways as they carry out the phosphoryla...
CHK2 is a checkpoint kinase involved in the ATM-mediated response to double-strand DNA breaks. Its p...
Protein kinases represent an attractive target in oncology drug discovery. Most of kinase inhibitors...
Protein kinases represent an attractive target in oncology drug discovery. Most of kinase inhibitors...
Protein kinases represent an attractive target in oncology drug discovery. Most of kinase inhibitors...
CHK2 is a checkpoint kinase involved in the ATM-mediated response to double-strand DNA breaks. Its p...
Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response to DNA d...
<div><p>Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response ...
Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response to DNA d...
Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response to DNA d...
Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response to DNA d...
5-(Hetero)aryl-3-(4-carboxamidophenyl)-2-aminopyridine inhibitors of CHK2 were identified from high ...
5-(Hetero)aryl-3-(4-carboxamidophenyl)-2-aminopyridine inhibitors of CHK2 were identified from high ...
5-(3-Chlorophenylamino)benzo[c] [2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical s...
Inhibition of the cell cycle is widely considered as a new approach toward treatment for diseases ca...
Protein kinases are key components in cellular signalling pathways as they carry out the phosphoryla...
CHK2 is a checkpoint kinase involved in the ATM-mediated response to double-strand DNA breaks. Its p...
Protein kinases represent an attractive target in oncology drug discovery. Most of kinase inhibitors...
Protein kinases represent an attractive target in oncology drug discovery. Most of kinase inhibitors...
Protein kinases represent an attractive target in oncology drug discovery. Most of kinase inhibitors...
CHK2 is a checkpoint kinase involved in the ATM-mediated response to double-strand DNA breaks. Its p...